Loading organizations...
Loading organizations...
Develops therapies targeting genetic diseases caused by splicing mutations.
Splisense has raised $16.9M across 2 funding rounds.
Splisense has raised $16.9M in total across 2 funding rounds.
Splisense has raised $16.9M in total across 2 funding rounds.
Splisense's investors include Cystic Fibrosis Foundation, William Skach.
Splisense has raised $16.9M across 2 funding rounds. Most recently, it raised $8.5M Other Equity in April 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 3, 2024 | $8.5M Other Equity | Cystic Fibrosis Foundation | |
| May 13, 2021 | $8.4M Series B | William Skach |